Tuesday, August 16, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

KV Pharmaceutical Co. defrauded shareholders with false and misleading statements about its generic drugs, a class action claims in St. Louis Federal Court.

Endo Pharmaceutical Holdings is buying Indevus Pharmaceuticals in an unfair transaction for $4.50 per share, shareholders say in Delaware Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...